Company Directory / Medopad Ltd

Business Description

At Medopad, we want to create a world where people can live longer. A world where the best minds continue doing their best work. A world where we can spend more time with our loved ones.

Our technology takes a modular approach which means we cover a wide variety of disease areas to deliver better and more personalised care by transforming the way patients and data interact with clinicians. Our Artificial Intelligence division uses data collected through our platform to generate predictive insights which will be able to detect life threatening medical conditions.

We partner closely with the world's largest healthcare systems, pharma companies, research institutes, insurers and technology companies like APPLE andTENCENT to solve some of the biggest problems in rare, chronic and complex disease monitoring.

We believe by combining data and medical know-how, we can predict complications that lead to rapid health deterioration or death. Medopad and Tencent are conducting trials to develop and validate algorithms that can potentially predict complications across a range of disease indications like Parkinson’s, Cancer and Heart Diseases.

Medopad and Tencent have partnered to bring A.I. and predictive analytics to the world of medicine. One of the first joint projects is the development of an A.I. technology system to support Parkinson’s patients and their clinicians. The Markerless Motion Capture and Analysis System (MMCAS) provides a highly accurate, real-time assessment of facial features and joint movements, identifying the frequency, range, and intensity of movement. The system is currently under clinical trial evaluation.

Registered Address

13th Floor Millbank Tower
21-24 Millbank
London
SW1P 4QP

Contact Details

Key Data

Sector
9537 Software
Company Number
07725451
Type
Private Limited Company
Company Age
8 years
Incorporated
August 2, 2011
Status
Active
Nature of Business
61900 - Other telecommunications activities
Year End
December 31
Accounts Due
September 30, 2020
Latest Accounts
December 31, 2018